ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,249,000 | +37.0% | 169,000 | +18.3% | 0.42% | +67.5% |
| Q1 2016 | $912,000 | +2.1% | 142,800 | 0.0% | 0.25% | +27.3% |
| Q4 2015 | $893,000 | +7.1% | 142,800 | 0.0% | 0.20% | +17.9% |
| Q3 2015 | $834,000 | -29.4% | 142,800 | 0.0% | 0.17% | -44.4% |
| Q2 2015 | $1,181,000 | -24.7% | 142,800 | -25.0% | 0.30% | -28.3% |
| Q1 2015 | $1,568,000 | -21.4% | 190,300 | -34.4% | 0.42% | +24.2% |
| Q4 2014 | $1,994,000 | +8.0% | 290,300 | -23.7% | 0.34% | -11.5% |
| Q3 2014 | $1,846,000 | -14.7% | 380,300 | +12.0% | 0.38% | -8.2% |
| Q2 2014 | $2,163,000 | +217.2% | 339,600 | +301.4% | 0.42% | +178.0% |
| Q1 2014 | $682,000 | – | 84,600 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |